NCT01354405View on ClinicalTrials.gov

Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Polycystic Liver Disease
Interventions
DRUG

Lanreotide

120 mg every 28 days intramuscular

Trial Locations (1)

6500HB

Radboud University Hospital, Nijmegen

Sponsors

Collaborators (1)

Ipsen
All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

Radboud University Medical Center

OTHER